Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 42:5)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004167 AN006917 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST002691 AN004364 MoTrPAC: Endurance exercise training study in young adult rats, Rat White Adipose Powder - Untargeted Lipidomics, Reversed-Phase Positive White adipose Rat Georgia Institute of Technology LC-MS
ST002685 AN004358 MoTrPAC: Endurance exercise training study in young adult rats, Rat Brown Adipose Powder - Untargeted Lipidomics, Reversed-Phase Positive Brown adipose Rat Georgia Institute of Technology LC-MS
ST002671 AN004343 MoTrPAC: Endurance exercise training study in young adult rats, Rat Lung Powder - Untargeted Lipidomics, Reversed-Phase Positive Lung Rat Georgia Institute of Technology LC-MS
ST002657 AN004329 MoTrPAC: Endurance exercise training study in young adult rats, Rat Kidney Powder - Untargeted Lipidomics, Reversed-Phase Positive Kidney Rat Georgia Institute of Technology LC-MS
ST001442 AN002410 Human Optic Nerve Glaucoma and Control Lipidomes Eye tissue Human Eye disease University of Miami MS(Dir. Inf.)
ST000917 AN001500 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000915 AN001488 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
  logo